1 year return (CAGR)
148.44%
Kymera Therapeutics Inc Exchange (NASDAQ, USD)
KYMR
122.06
+4.39 (+3.73%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
85.73%
5 year return (CAGR)
14.08%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
10.04B
Price/Sales
95.63
Ent value
10.06B
Price/Book
6.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
7.02%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 119.03 |
| Daily high | 122.29 |
| Daily low | 117.88 |
| Daily Volume | 779K |
| All-time high | 127.31 |
| 1y analyst estimate | 134.95 |
| Beta | 1.95 |
| EPS (TTM) | -3.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| KYMR | S&P500 | |
| Current price drop from All-time high | -4.12% | -0.58% |
| Highest price drop | -87.51% | -56.47% |
| Date of highest drop | 27 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -47.32% | -10.68% |
| Avg time to new high | 39 days | 12 days |
| Max time to new high | 1242 days | 1805 days |
News
